Gates Foundation invests $40 mln in UK immunotherapy company – Reuters
The Times |
Gates Foundation invests $40 mln in UK immunotherapy company
Reuters LONDON, Sept 18 (Reuters) – The Bill & Melinda Gates Foundation is to invest up to $40 million in privately held British biotech company Immunocore to support its development of immunotherapies for infectious diseases. Oxford-based Immunocore has so … Gates foundation invests in British immunotherapy specialist |
